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Ontologies for clinical and translational research: Introduction1. Background
Ontologies are representational artifacts that are being used in
many different ways by researchers in almost every life science
discipline. Their use in the annotation of both clinical and experi-
mental data is now a common approach for knowledge representa-
tion in support of integrative translational research. When high
quality ontologies are used correctly and consistently, then the
description of the relevant entities and the semantic framework
for capturing their relationships support not only the retrieval
and integration of data, but also algorithmic reasoning, and seman-
tic enhancement of the published literature and database records.
The expanded use of ontologies is therefore being encouraged by
recent mandates promulgated by the National Institutes of Health
(NIH) and other funding agencies requiring researchers to provide
plans to ensure reusability of the data deriving from funded
research.
This special issue on Ontologies for Clinical and Translational
Research focuses on ways in which ontologies can contribute to
breaking down the barriers between different sorts of information
relevant to the understanding and treatment of disease, ranging
from information deriving from experimental biology and model
organism research to clinical trial data and information of the sort
contained in electronic health records. It is clear that the develop-
ment and use of well-formulated ontologies are still in their early
stages; the manuscripts presented in this special issue represent
both the state of the art and works in progress. We still have a con-
siderable way to go to reach the level of domain coverage and
semantic consistency sought by those engaged in information-
driven clinical and translational research. Thus the inclusion in this
issue of the Journal of Biomedical Informatics of papers discussing
one or other ontology should not be seen as an unconditional
endorsement for the use of the ontologies discussed.
From the combined experience of the groups reporting their re-
sults here and elsewhere, several common themes emerge that will
be helpful in guiding future development and use of ontologies.
1. The Basic Formal Ontology (BFO) [http://www.ifomis.
uni-saarland.de/bfo/] has been found to provide a valuable
framework for the development of a wide range of different
biomedical ontologies by over 75 biomedical ontologist
groups. The initial classiﬁcation of entities to be represented
in an ontology into the three main axes of the BFO –
independent continuants, dependent continuants and
occurrents – establishes a consistent framework for the
resulting subsumption hierarchy. This relatively simple step
has had a dramatic impact on the overall quality and consis-
tency of the resultant ontologies.1532-0464/$ - see front matter  2011 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2011.01.0022. The principles proposed by the Open Biomedical Ontology
(OBO) Foundry [http://obofoundry.org] have been found to
be useful in providing guidance to ontology developers
about best practices in ontology development and reducing
the proliferation of overlapping ontologies. Rather than
supporting the independent development of alternative
ontologies covering the same biomedical domain, the OBO
Foundry has encouraged the establishment of collaborative
groups that come together to work on a common ontology
for a given domain that is constructed to support the needs
of all of the involved stakeholders [1]. In addition, this
approach has allowed individuals in need of terms to repre-
sent entities that cross many different biomedical domains
to contribute to the relevant ontology development projects
in a way that ensures a high degree of cross-domain
consistency.
3. It has become clear that a critical component of ontology-
based annotation is the use of a consistent set of relations
that establishes the semantic framework for knowledge rep-
resentation. It has also become clear that in order to serve
this function, the proliferation of new relations must be
tightly controlled and coordinated. The Relation Ontology
(RO) [2] has emerged as a critical OBO Foundry reference
ontology for this purpose. By tightly controlling the number
of relations, the RO can be incorporated into inferencing and
other reasoning algorithms that can then traverse the
resulting semantic network.
4. There is much value to be gained by reusing terms from
existing ontologies in formulating logical deﬁnitions and
compound terms, and by importing terms and deﬁnitions
from existing ontologies using the ‘‘Mireoting’’ strategy
[3]. This not only makes the process of covering new bio-
medical domains more efﬁcient, it is also helpful in ensuring
the coherence of the entire semantic network.
At the same time, several signiﬁcant challenges have been
noted by those faced with more sophisticated terminological
needs. The ﬁrst is the lack of complete domain coverage. While
many groups of researchers may recognize the value of incorporat-
ing well-formulated ontologies into their representational frame-
work, they must also determine how they will deal with the
many sorts of entities that are not currently found in the relevant
source ontologies. While the developers of existing OBO Foundry
ontologies have committed themselves to be responsive to term
requests submitted by members of user communities, provision
of new terms can be a lengthy process, not only because the devel-
opment and validation of accurate deﬁnitions for single terms is
not always a simple process, but also because the need for careful
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imply the need for the creation of new sub-branches of additional
new terms. In addition, resource limitations mean that for some
biomedical domains ontologies do not yet exist. In many cases,
therefore, a user will need to decide what kind of interim solution
to adopt while waiting for acceptable domain coverage.
Finally, much of the current knowledge derived from biomedi-
cal research and biomedical informatics has been represented
using legacy terminologies that did not incorporate a consistent
semantic framework. Rather than discarding this legacy knowl-
edge, most groups would prefer to adopt some kind of strategy
for mapping between legacy vocabularies and the emerging ontol-
ogies. Unfortunately, few automated mapping strategies have been
developed, making this a largely manual process that does not
scale well to the current corpus of available knowledge. For the
broad adoption of these new ontologies, it will be critical to devel-
op better strategies for importing legacy information into more
modern ontological frameworks that are both logically consistent
and biologically coherent.2. Contents of this issue
The manuscripts included in this special issue include work on
both the development and use of ontologies. It has become clear
that for successful ontology initiatives, development and use must
go hand in hand. Ontologies created on the basis of a consistent
logical framework must be tested and reﬁned through large-scale
application in data and literature annotation if they are to be of
high utility in advancing data integration and reuse across a broad
sweep of further applications, and if they are to support a variety of
secondary uses not anticipated when the ontology was originally
conceived.
In order to guide readers through this issue, we summarize the
key characteristics of each paper below.
3. Original research
 ‘‘The ACGT Master Ontology and Its Applications – Towards
an Ontology-Driven Cancer Research and Management Sys-
tem’’ [4].
Here Brochhausen et al. report on the development and use of an
application ontology to support cancer research. The goal is to pro-
vide the semantics for a grid-based services infrastructure that will
enable efﬁcient execution of discovery-driven workﬂows in the
context of multi-center, post-genomic clinical trials. The ontology
is designed on the basis of the following principles: (1) adoption
of a radically restrictive deﬁnition of the term ‘ontology’ in compli-
ance with the principles of ontological realism; (2) enforcement of
a strict subsumption hierarchy, based on a formally speciﬁed is_a
relation; (3) avoidance of multiple inheritance in the hierarchy of
universals; (4) avoidance of the types of confusions between ontol-
ogy and epistemology illustrated by terms such as ‘unknown X’,
‘unlocalized Y’, and so forth; (5) use of BFO as the upper ontology;
and (6) use of the OBO Relation Ontology (RO) for the semantic
structure. A prior analysis revealed that SNOMED-CT, the NCI
Thesaurus, and the UMLS, did not meet these requirements and
therefore could not be used for the intended purpose. The ACGT
ontology here presented is still marked by compromises designed
to address ‘clinical needs’, but its authors are aware that work is
still needed to ensure that these needs are addressed in a princi-
pled way that will allow consistency with other OBO Foundry
candidate ontologies. ‘‘Towards an Ontological Theory of Substance Intolerance
and Hypersensitivity’’ [5].
Here William Hogan outlines a realist approach to the ontology of
substance intolerance. Building further on the Ontology for General
Medical Science [6], he characterizes substance intolerance as a
disease whose pathological processes are realized upon exposure
to a quantity of substance of a particular type, and such that this
quantity would normally not cause the realization of the patholog-
ical processes in question. His theory makes a careful distinction
between a disposition to undergo particular processes, and the
processes themselves, a considerable improvement over what is
said in terminological artifacts such as SNOMED CT and MedDRA,
which blur this important distinction. He also reviews and incorpo-
rates the three major axes on which these diseases are typically
classiﬁed: the pathological process to which the organism is dis-
posed, the location within the organism where the pathological
process occurs, and the substance that induces the pathological
process.
 ‘‘Towards an Ontological Representation of Resistance: The
Case of MRSA’’ [7].
Here Goldfain et al. provide a characterization of the phenomenon
of resistance in terms of what they call ‘blocking dispositions,’ by
which they mean collections of mutually coordinated dispositions
which are such that they cannot undergo simultaneous realization
within a single bearer. The approach, which builds on BFO and on
the Gene Ontology (GO), introduces some additional principles, of
which the ‘‘nonproliferation of new relations and terms’’ is a most
welcome alternative to the more common solutions in which rela-
tions are generated ad libitum, without serious ontological analysis.
As the authors argue, it would indeed be easier to invent the rela-
tion ‘‘resistant to’’ and use it to describe every instance of a resis-
tance phenomenon. But this would hide the complexity of the
mechanisms of resistance working at a smaller scale, and eliminate
many important inferences about resistance. The applicability of
the approach is demonstrated by examples of drug resistance in
Methicillin-Resistant Staphylococcus aureus (MRSA), HIV and
malaria.
 ‘‘A Set of Ontologies to Drive Tools for the Control of Vector-
Borne Diseases’’ [8].
This paper, by Pantelis Topalis and colleagues, describes work thus
far on an ontology for vector-borne diseases based on the Infec-
tious Disease Ontology (IDO). The paper describes a survey of the
available resources and tools, and of some of the potential applica-
tions of such an ontology, particularly in the consistent design of
disease databases in a way which can allow the construction of
decision support systems (DSS) to control malaria, dengue, yellow
fever and other diseases of global signiﬁcance.
 ‘‘Toward an Ontology-Based Framework for Clinical
Research Databases’’ [9].
In this paper Kong et al. describe a data model for clinical research
data which is designed around the logical structure of the BFO and
the Ontology for Biomedical Investigations (OBI). The model is
designed to simplify the development of data dictionaries based
on ontologies from the OBO Foundry. Existing clinical data
standards, all centered around CDISC, were analyzed and found
to fall short in several respects. The paper presents a practical
application of OBO Foundry ontologies for the design of an exten-
sible database schema to capture and manage data from a wide
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ported by the US National Institute of Allergy and Infectious Dis-
eases (NIAID).
 ‘‘NanoParticle Ontology for Cancer Nanotechnology
Research’’ [10].
This paper by Nathan Andrew Baker discusses the design and
development of an ontology relating to the preparation, chemical
composition, and characterization of nanomaterials involved in
cancer research. While the ontology is in part developed within
the framework of the BFO, it does not yet satisfy all of the associ-
ated principles. For example, the authors employ many relations
that do not conform to the rules set forth in the Relation Ontology
(RO); there are also confusions between dependent and indepen-
dent continuants, speciﬁcally at the level of realizable entities, dis-
jointness of classes is not enforced, and so forth. This work serves
nonetheless as an important ﬁrst step towards the needed nano-
particle ontology, and it clearly illustrates the potential applica-
tions of such an ontology in supporting information-driven
cancer research.
 ‘‘Hematopoietic Cell Types: Prototype for a Revised Cell
Ontology’’ [11].
This paper, by Diehl et al., describes the major modiﬁcations that
have been introduced into those portions of the Cell Ontology
(CL) dealing with hematopoietic cells. This revision is part of a lar-
ger initiative to bring the CL up to current standards for biomedical
ontologies, both in its structure and its coverage of various sub-
ﬁelds of biology, to transform the ontology into an OBO Foundry
reference ontology. The achievements obtained include the elimi-
nation of multiple inheritance in the asserted hierarchy and the
groundwork for structuring the hematopoietic cell type terms as
cross-products incorporating logical deﬁnitions built from rela-
tionships to external ontologies, such as the Protein Ontology
and the Gene Ontology.
 ‘‘Cross-Product Extensions of the Gene Ontology’’ [12].
This paper by Mungall et al. provides preliminary results of on-
going work to normalize the GO by providing deﬁnitions for Gene
Ontology (GO) terms in a logical form that can be used by reason-
ers. These deﬁnitions draw on a partitioning of terms into
mutually exclusive sets, corresponding for example to the OBO
Foundry candidate ontologies for chemical entities, proteins, bio-
logical qualities and anatomical entities. The advantage of these
logical deﬁnitions is that they have the potential to allow the
automation of many aspects of ontology development, of detect-
ing errors and of ﬁlling in missing relationships. These deﬁnitions
also enhance the GO by weaving it into the fabric of a wider col-
lection of interoperating ontologies, increasing opportunities for
data integration and enhancing genomic analyses. A novelty in
the approach is that the traditional ontology development sce-
nario, in which reasoners are used to infer the subsumption hier-
archy of composite classes based on properties described in terms
of simpler classes, is complemented by a form of inverse, abduc-
tive reasoning, in which inferences are drawn from the GO to ref-
erenced ontologies such as the CL or ChEBI. This makes it possible
to ﬁnd inconsistencies within the GO and between the GO and
other ontologies, and to uncover a number of fundamental differ-
ences between classiﬁcations in ChEBI and in the implicit chem-
ical entity ontology in GO.
 ‘‘Evolution of the Sequence Ontology Terms and Relation-
ships’’ [13].Here Mungall et al. report on recent improvements in the Sequence
Ontology, focusing on new relationships included in the ontology
in order to better deﬁne the mereological, spatial and temporal
aspects of biological sequences. Although deﬁnitions for these
new relationships are provided, these do not follow the format pro-
posed by the RO; for instance they do not require that instance-
level relationships between continuants should be time-indexed,
thereby raising the question whether molecules, because of the
ways we refer to them using chemical formulae, are governed by
different rules governing changes such as gain and loss of parts
from those which govern entities such as cells and organisms.
 ‘‘Desiderata for Ontologies to Be Used in Semantic Annota-
tion of Biomedical Documents’’ [14].
In this paper Bada and Hunter report on their effort manually to
annotate 97 full-text biomedical journal articles with terms
derived predominantly from OBO ontologies. They argue that these
ontologies contain infelicities with respect to their use in semantic
annotation of biomedical documents, and propose desiderata
whose implementation could, in their view, improve their utility
for this purpose. The desiderata include integration of overlapping
terms across OBO ontologies, the resolution of OBO-speciﬁc ambi-
guities, the integration of BFO with the OBO ontologies, the use of
mid-level ontologies, the inclusion of non-canonical instances, and
the expansion of relations and realizable entities. Their work dem-
onstrates clearly the need for principles of the sort advocated by
the OBO Foundry, adherence to which has the potential to avoid
many of the problems they identify.
4. Applications
 vSPARQL: A View Deﬁnition Language for the Semantic
Web’’ [15].
The paper by Marianne Shaw et al. describes a view deﬁnition lan-
guage, vSPARQL, that allows for the speciﬁcation of subsets of
data/information (views) represented in RDF or OWL for access
through semantic web technologies. In addition, vSPARQL also
allows for the reorganization andmodiﬁcation of the source content
to meet speciﬁc use cases not easily supported by the native data
structures. The authors demonstrate the use of vSPARQL for the
extraction and modiﬁcation of data from the NCI Thesaurus, Reac-
tome, Ontology of Physics for Biology and the Foundational Model
of Anatomy to support a series of biological use cases (e.g. generate
a liver anatomy sub-ontology from the FMA that excludes all rela-
tions other than is_a or part_of for use in the annotation of radiology
images). Finally, the authors compare the use of vSPARQLwith other
existing RDF query languages against the deﬁned requirements.
 ‘‘An Ontology-Based Measure to Compute Semantic Similar-
ity in Biomedicine’’ [16].
This paper by Montserrat Batet and collaborators addresses the
problem of automatic knowledge extraction from text, focusing
on the issue of measuring semantic similarity between word pairs.
It surveys existing approaches to this issue in the ﬁeld of biomed-
icine, and proposes a new approach which uses the taxonomical
structure of biomedical ontologies and vocabularies such as
SNOMED CT. The proposal is shown to enhance accuracy in identi-
fying semantically similar word pairs as compared to some exist-
ing approaches.
 ‘‘Using an ECG reference ontology for Semantic Interopera-
bility of ECG data’’ [17].
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reference ontology for electrocardiograms can be used for semantic
integration of ECG data standards (e.g. Physionet, SCP-ECG and HL7
aECG). Integration is achieved by mapping the individual represen-
tations to a common reference ontology developed by the authors
in order to provide a consistent realism-based conceptualization of
the entities of interest. The uses and advantages of this approach
for data integration remain to be demonstrated.
 ‘‘The Biomedical Resource Ontology (BRO) to Enable
Resource Discovery in Clinical and Translational Research’’
[18].
This paper by Tenenbaum et al. describes the development and use
of the Biomedical Resource Ontology (BRO) and of associated soft-
ware tools. The BRO is designed to facilitate semantically based
search and discovery of funding, material, software, training and
other resources for biomedical research. The ontology contains also
a terminological component dealing with areas of research and
with activities such as community engagement and device
development.
 ‘‘Multiple Ontologies in Action: Composite Annotations for
Biosimulation Models’’ [19].
Here Gennari et al. report on their proposal to use what they call
‘‘composite annotations’’ to access multiple ontologies in a way
that will capture the physics-based meaning of model variables.
They argue that these composite annotations can ‘‘provide the
semantic expressivity needed to disambiguate the often-complex
features of biosimulation models, and can be used to assist with
model merging and interoperability’’. To that end, they provide a
simple juxtaposition grammar and describe a tool based on this
grammar which allows users to select terms from various ontolo-
gies that then are used as elementary building blocks for the
desired composite annotations.
 ‘‘Ontology Modularization to Improve Semantic Medical
Image Annotation’’ [20].
Here Pinar Wennerberg and colleagues describe an ontology-based
strategy for image annotation that enables images and clinical
reports to be linked via common annotations. In part because of
the large size of clinical ontologes, the creation of such descriptions
involves a considerable investment of effort. The authors propose a
modularization strategy to address this problem, based on identi-
ﬁcation of ontology fragments relevant to particular sets of images,
They illustrate this strategy by showing how it can identify terms
in the Foundational Model of Anatomy [21] relevant for annotating
medical images from patients suffering from lymphoma.
5. Methodological review
 ‘‘Natural Language Processing Methods and Systems for Bio-
medical Ontology Learning’’ [22].
This paper by Liu et al. is a thorough review of methods to
address the increasingly pressing problems for clinical and transla-
tional ontologies that arise as a result of the use of manual,
time-consuming, and often error-prone process methods of ontol-
ogy development. The authors survey multiple techniques for
automating the enrichment of an ontology from free-text docu-
ments. They conclude that, while fully automated acquisition of
ontology by machines is not likely in the near future, there ispotential value to be gained from semi-automatic ontology learn-
ing approaches that include human intervention.6. Conclusion
Considerable progress toward the goal of the development and
use of well-formulated ontologies has been made in the last
decade. As the user community applies the resulting ontologies
to addresses data annotation and data mining challenges, their
experience will feed back to the ontology development community
to further improve the structures represented in the relevant
ontologies. While there is still a long way to go to realize this goal,
we believe that the work reported here indicates that we are
heading in the right direction.Acknowledgments
The majority of the contributions to this issue are based on pa-
pers presented at the ﬁrst International Conference on Biomedical
Ontology held in Buffalo, NY in July 2009. We are grateful for the
support of the National Institutes of Health and of the National
Human Genome Research Institute through the NIH Roadmap for
Medical Research Grant 1 U 54 HG004028 and through conference
Grant 1 R13 HG005049-01. We also gratefully acknowledge the
many helpful contributions provided by Janine Burch at all stages
in the preparation of this special issue.References
[1] Smith B, Ashburner M, Rosse C, Bard J, Bug W, Ceusters W, et al. The OBO
foundry: coordinated evolution of ontologies to support biomedical data
integration. Nature Biotechnol 2007;25(11):1251–5. PMID: 17989687.
PMC2814061.
[2] Smith B, Ceusters W, Klagges B, Köhler J, Kumar A, Lomax J, et al. Relations in
biomedical ontologies. Genome Biol 2005;6(5):R46. PMC: 1175958.
[3] Courtot M, Gibson F, Lister A, Malone J, Schober D, Brinkman R, et al. MIREOT:
the minimum information to reference an external ontology term. In:
Proceedings of international conference on biomedical ontology. Nature
proceedings; 2009. <http://precedings.nature.com/documents/3576>.
[4] Brochhausen M, Spear AD, Cocos C, Weiler G, Martı`n L, Anguita A, et al.
The ACGT master ontology and its applications – towards an ontology-
driven cancer research and management system. J Biomed Inform 2011;44(1):
8–25.
[5] Hogan WR. Towards an ontological theory of substance intolerance and
hypersensitivity. J Biomed Inform 2011;44(1):26–34.
[6] Scheuermann RH, Ceusters W, Smith B. Toward an ontological treatment of
disease and diagnosis. In: AMIA 2009 summit on translational bioinformatics
proceedings; 2009. p. 116–20..
[7] Goldfain A, Smith B, Cowell LG. Towards an ontological representation of
resistance: the case of MRSA. J Biomed Inform 2011;44(1):35–41.
[8] Topalis P, Dialynas E, Mitraka E, Deliyanni E, Siden-Kiamos I, Louis C. A set of
ontologies to drive tools for the control of vector-borne diseases. J Biomed
Inform 2011;44(1):42–7.
[9] Kong YM, Dahlke C, Xiang Q, Qian Y, Karp D, Scheuermann RH. Toward an
ontology-based framework for clinical research databases. J Biomed Inform
2011;44(1):48–58.
[10] Baker NA. Nanoparticle ontology for cancer nanotechnology research. J Biomed
Inform 2011;44(1):59–74.
[11] Diehl D, Deckhut -Augustine A, Blake JA, Cowell LG, Gold ES, Gondré-Lewis TA,
et al. Hematopoietic cell types: prototype for a revised cell ontology. J Biomed
Inform 2011;44(1):75–9.
[12] Mungall CJ, Bada M, Berardini TZ, Deegan J, Ireland A, Harris MA, et al.
Cross-product extensions of the gene ontology. J Biomed Inform 2011;44(1):
80–6.
[13] Mungall CJ, Batchelor C, Eilbeck K. Evolution of the Sequence Ontology terms
and relationships. J Biomed Inform 2011;44(1):87–93.
[14] Bada M, Hunter L. Ontology desiderata for their use in semantic annotation of
biomedical documents. J Biomed Inform 2011;44(1):94–101.
[15] Shaw M, Detwiler LT, Noy N, Brinkley J, Suciu D. vSPARQL: a view deﬁnition
language for the semantic web. J Biomed Inform 2011;44(1):102–17.
[16] Batet M, Sanchez D, Valls A. An ontology-based measure to compute semantic
similarity in biomedicine. J Biomed Inform 2011;44(1):118–25.
[17] Gonçalves B, Guizzardi G, Pereira Filho JG. Using an ECG reference ontology
for semantic interoperability of ECG data. J Biomed Inform 2011;44(1):
126–36.
Guest Editorial / Journal of Biomedical Informatics 44 (2011) 3–7 7[18] Tenenbaum JD, Whetzel P, Anderson K, Borromeo CD, Dinov ID, Gabriel D,
et al. The Biomedical Resource Ontology (BRO) to enable resource
discovery in clinical and translational research. J Biomed Inform 2011;44(1):
137–45.
[19] Gennari J, Neal M, Galdzicki M, Cook D. Multiple ontologies in action:
composite annotations for biosimulation models. J Biomed Inform
2011;44(1):146–54.
[20] Wennerberg P, Schulz K, Buitelaar P. Ontology modularization to improve
semantic medical image annotation. J Biomed Inform 2011;44(1):155–62.
[21] Rosse C, Mejino JLV. The foundational model of anatomy ontology. In: Burger A
et al., editors. Anatomy ontologies for bioinformatics: principles and
practice. New York: Springer; 2007. p. 59–117.
[22] Liu K, Hogan WR, Crowley RS. Natural Language Processing methods and
systems for biomedical ontology learning. J Biomed Inform 2011;44(1):
163–79.Barry Smith
University at Buffalo,
135 Park Hall, Buffalo, NY 14260,
United States
E-mail address: phismith@buffalo.edu
Richard H. Scheuermann
University of Texas Southwestern Medical Center,
5323 Harry Hines Blvd.
Dallas, TX 75390-9072,
United States
E-mail addresses: richard.scheuermann@utsouthwestern.edu
